Press release
Meningococcal Vaccines Market to Record Study Growth by 2021
Request Sample Copy of the Report@
https://www.persistencemarketresearch.com/samples/3640
Based on various cause of the disease, meningitis is classified into two main types: non-infectious meningitis and infectious meningitis. Non-infectious meningitis is a type of aseptic meningitis. Aseptic meningitis is caused by something other than the bacteria that typically cause acute meningitis. Non-infectious meningitis does not spread from person to person. Infectious meningitis is further sub-divided into bacterial meningitis, fungal meningitis, viral meningitis and parasitic meningitis. Bacterial meningitis is extremely severe form of the disease which is caused by bacteria such as Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumonia. These bacteria can spread from person to person through coughing and sneezing. Viral meningitis is mainly occurred by diarrhea causing virus. Fungal meningitis is rare in healthy people. However, person who has an impaired immune system is more prevalent with this form of the disease.
Septicemia arises from infections throughout the body. It includes infections in the lungs, urinary tract and abdomen. Meningococcemia is also caused by bacterium Neisseria meningitidis.
The global meningococcal vaccines market is segmented into conjugate vaccines, polysaccharide vaccines and combination vaccines. Conjugate vaccines reduce incidences of bacterial meningitis. This is due to prolonged immunization influence of the vaccine which is developed for various serogroups of bacteria. Major brands of conjugate vaccines include MenAfriVac, Nimenrix, Menactra, Meningitec, NeisVac-C and Menveo.
Polysaccharide provides immunity for a short period of time. Major brands of polysaccharide vaccines include NmVac4, Menomune, Bi Meningo, Mencevax and Quadri Meningo.
Combination vaccines are prepared with the combination of other microorganism. Major brands of combination vaccines include Menitorix and MenHibrix.
In terms of geographic, North America dominates the global meningococcal vaccines market. This is due to increased healthcare awareness in the region. The U.S. represents the largest market for meningococcal vaccines followed by Canada in North America. In Europe, France, Germany and the U.K. holds major share of meningococcal vaccines market. However, Asia is expected to show high growth rates in the next five years in global meningococcal vaccines market. This is due to increasing awareness among people about meningitis in the region. Several government associations have launched various immunization programs and awareness campaigns to provide education about meningococcal disease. Japan, China and India are expected to be the fastest growing meningococcal vaccines markets in Asia.
In recent time, increased government support is key driver for the global meningococcal vaccines market. Various government associations have launched mandate immunization programs for school children. This increases the demand of meningococcal vaccines to provide immunity against meningococcal disease.
However, stringent regulations hamper the growth of global meningococcal vaccines market. Increasing mergers and acquisitions between manufacturing companies and government bodies and rapid product launches are some of the major trends of global meningococcal vaccines market.
Request TOC of the Report@
https://www.persistencemarketresearch.com/toc/3640
Some of the major companies operating in the global meningococcal vaccines market are GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG, Sanofi SA, Pfizer, Inc. and Baxter International, Inc..
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market to Record Study Growth by 2021 here
News-ID: 758353 • Views: …
More Releases from Transparency Market Research
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036.
Thermal management has become a mission-critical function in…
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036.
Review critical insights and findings from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920
This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,…
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation…
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise.
The global Tablet Hardness Testers…
More Releases for Meningo
Meningococcal Vaccines Market to Cross US$ 4.4 Billion Globally by 2022
New York, April 24: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Global Meningococcal Vaccines Market by Combination-, Conjugate-, Polysaccharide …
The global meningococcal vaccines market is estimated to reach US$ 4.3 Bn in 2021, expanding at a CAGR of 12.6% from 2017 to 2021, due to technological advancement and its rapid adoption worldwide.
Browse Meningococcal Vaccines Market by Meningococcal Combination Vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal Conjugate Vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); and Meningococcal Polysaccharide Vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo) and Forecast 2017-2021…
Meningococcal Vaccines Market Worth US$ 4.4 Billion Globally by 2022
New York, April 06: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Exceed US$ 4.4 Billion by 2022
New York, March 16: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Reach US$ 4.4 Billion by 2022
New York, March 08: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Cross US$ 4.4 Billion by 2022
New York, February 27: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
How Big is the Global Meningococcal Vaccines Market?
The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.4 billion by 2022 and will grow at a CAGR of more…
